1. Home
  2. LIVE vs NEUP Comparison

LIVE vs NEUP Comparison

Compare LIVE & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Live Ventures Incorporated

LIVE

Live Ventures Incorporated

N/A

Current Price

$10.06

Market Cap

32.7M

ML Signal

N/A

NEUP

Neuphoria Therapeutics Inc.

HOLD

Current Price

$5.30

Market Cap

28.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIVE
NEUP
Founded
1968
1996
Country
United States
United States
Employees
N/A
8
Industry
Other Specialty Stores
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
32.7M
28.7M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
LIVE
NEUP
Price
$10.06
$5.30
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$21.00
AVG Volume (30 Days)
9.3K
39.9K
Earning Date
05-14-2026
05-23-2026
Dividend Yield
N/A
N/A
EPS Growth
158.14
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.03
$3.65
52 Week High
$25.42
$21.31

Technical Indicators

Market Signals
Indicator
LIVE
NEUP
Relative Strength Index (RSI) 42.08 54.93
Support Level $10.25 $3.91
Resistance Level $14.26 $5.45
Average True Range (ATR) 1.11 0.31
MACD -0.03 0.01
Stochastic Oscillator 40.66 74.11

Price Performance

Historical Comparison
LIVE
NEUP

About LIVE Live Ventures Incorporated

Live Ventures Inc is a holding company of diversified businesses. It acquires and operates companies with a history of earnings power across five segments: Retail-Entertainment, Retail-Flooring, Flooring Manufacturing, Steel Manufacturing, and Corporate & Other. Retail-Entertainment offers new and pre-owned movies, video games, music, books, comics and collectibles through an integrated buy-sell-trade model. Retail-Flooring is a retailer and installer of flooring, carpeting, and countertops, serving consumers, builders, and contractors. Flooring Manufacturing produces and distributes carpet and hard-surface flooring. Steel Manufacturing engages in steel production and fabrication, generating the majority of revenue. Corporate & Other covers corporate costs and legacy products and services.

About NEUP Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.

Share on Social Networks: